机器人减重手术在修正性胃旁路术中较腹腔镜降低并发症
该研究基于MBSAQIP数据库2015—2022年41,404例修正性减重手术(袖状胃切除14,474例、Roux-en-Y胃旁路26,930例),比较腹腔镜与机器人入路的30天结局。结果显示机器人修正性RYGB总体并发症、输血、表浅切口感染及住院时间均低于腹腔镜,但手术时间更长;修正性SG两种入路结局相似。
要点
- 机器人修正性RYGB总体并发症低于腹腔镜(4.8% vs 6.2%,AOR 0.80)。
- 机器人修正性SG与腹腔镜结局相似,但手术时间更长。
- 修正性减重手术中机器人使用比例逐年上升。
核心结论
- 在修正性Roux-en-Y胃旁路术中,机器人入路较腹腔镜降低术后总体并发症并缩短住院时间。
- 机器人平台可能改善修正性减重手术患者的诊疗质量。
研究设计与样本
- MBSAQIP数据库回顾性研究,纳入2015—2022年修正性袖状胃切除与Roux-en-Y胃旁路病例。
- 共纳入41,404例(袖状胃切除14,474例;Roux-en-Y胃旁路26,930例),排除初次减重手术、开放/急诊、中转及联合手术病例。
- 采用多因素logistic回归校正人口学、合并症与手术变量后比较腹腔镜与机器人30天结局。
主要发现
- 机器人修正性袖状胃切除比例从6.1%升至24.2%,修正性Roux-en-Y胃旁路从7.3%升至32.0%。
- 腹腔镜修正性袖状胃切除在总体并发症、漏、出血、再入院、再手术及住院时间上与机器人相似。
- 腹腔镜修正性Roux-en-Y胃旁路总体并发症(6.2% vs 4.8%,p<0.001,AOR 0.80[0.70-0.93])、输血(1.5% vs 1.0%,p<0.05,AOR 0.74[0.55-0.99])、表浅切口感染(1.2% vs 0.4%,p<0.001,AOR 0.30[0.19-0.47])及住院时间(1.87 vs 1.76天,p<0.001)均高于机器人。
- 腹腔镜手术时间显著短于机器人(袖状胃切除86.4±45.8 vs 113.5±51.7分钟;Roux-en-Y胃旁路130.7±64.7 vs 165.5±66.8分钟,p<0.001)。
临床怎么用
- 修正性Roux-en-Y胃旁路可优先考虑机器人入路以降低总体并发症、输血与表浅切口感染并缩短住院时间。
- 修正性袖状胃切除选择机器人或腹腔镜需权衡手术时间延长的代价。
局限性
- 为回顾性数据库研究,可能存在选择偏倚与未测混杂。
- 仅分析30天结局,缺乏长期随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Robotic-assisted metabolic and bariatric surgery (MBS) is gaining popularity. Revisional MBS is associated with higher perioperative morbidity compared to primary MBS. The optimal surgical approach to minimize complications in these complex cases is unclear. The goal of this study was to assess robot utilization in revisional MBS and compare laparoscopic and robotic revisional MBS outcomes in the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database. METHODS: A retrospective review of the MBSAQIP database was performed identifying revisional sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) cases from 2015 to 2022. Primary MBS, open/emergent cases, cases converted to another approach, and combined cases other than esophagogastroduodenoscopy were excluded. 30-Day outcomes for laparoscopic and robotic cases were compared using multivariate logistic regression adjusting for patient demographics, comorbidities, and operative variables. RESULTS: 41,404 Cases (14,474 SG; 26,930 RYGB) were identified. From 2015 to 2022, the percentage of revisional SG and RYGB cases performed robotically increased from 6.1% and 7.3% to 24.2% and 32.0% respectively. Laparoscopic SG had similar rates of overall morbidity, leak, bleeding, readmission, reoperation, and length of stay compared to robotic. Laparoscopic RYGB had significantly higher rates of overall morbidity (6.2% vs. 4.8%, p < 0.001, AOR 0.80 [0.70-0.93]), blood transfusion (1.5% vs. 1.0%, p < 0.05, AOR 0.74 [0.55-0.99]), superficial incisional SSI (1.2% vs. 0.4%, p < 0.001, AOR 0.30 [0.19-0.47]), and longer length of stay (1.87 vs. 1.76 days, p < 0.001) compared to robotic. Laparoscopic operative times were significantly shorter than robotic (SG: 86.4 ± 45.8 vs. 113.5 ± 51.7 min; RYGB: 130.7 ± 64.7 vs. 165.5 ± 66.8 min, p < 0.001). CONCLUSION: Robot utilization in revisional bariatric surgery is increasing. Robotic surgery has lower postoperative morbidity and shorter length of stay in revisional RYGB when compared to laparoscopic. Robotic platforms may have the capacity to improve the delivery of care for patients undergoing revisional bariatric surgery.
引用
- Spurzem GJ, Broderick RC, Kunkel EK, et al. Robotic bariatric surgery reduces morbidity for revisional gastric bypass when compared to laparoscopic: outcome of 8-year MBSAQIP analysis of over 40,000 cases. Surg Endosc. 2024. PMID: 39179689. doi:10.1007/s00464-024-11192-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。